Britain's GW Pharma to cancel London listing
October 19, 2016 at 02:34 AM EDT
Oct 19 (Reuters) - Britain's GW Pharmaceuticals Plc said it planned to cancel its listing in London's junior market and would retain listing of its American Depositary Receipts (ADRs) on New York's Nasdaq to simplify trading and cut expenses of dual listing.